These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12115253)
1. Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent: comment on the article by Pisetsky and the letter from Aringer et al. Fautrel B; Foltz V; Frances C; Bourgeois P; Rozenberg S Arthritis Rheum; 2002 May; 46(5):1408-9; author reply 1409. PubMed ID: 12115253 [No Abstract] [Full Text] [Related]
2. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. De Bandt M; Sibilia J; Le Loët X; Prouzeau S; Fautrel B; Marcelli C; Boucquillard E; Siame JL; Mariette X; Arthritis Res Ther; 2005; 7(3):R545-51. PubMed ID: 15899041 [TBL] [Abstract][Full Text] [Related]
3. Paraplegia in a patient receiving anti-tumor necrosis factor therapy for rheumatoid arthritis: comment on the article by Mohan et al. van der Laken CJ; Lems WF; van Soesbergen RM; van der Sande JJ; Dijkmans BA Arthritis Rheum; 2003 Jan; 48(1):269-70. PubMed ID: 12528130 [No Abstract] [Full Text] [Related]
4. Intraarticular injection of anti-tumor necrosis factor: Comment on the letter by Arnold et al. Bliddal H Arthritis Rheum; 2004 Jun; 50(6):2037-8. PubMed ID: 15188385 [No Abstract] [Full Text] [Related]
5. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents. Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227 [No Abstract] [Full Text] [Related]
6. Lessons from magnetic resonance imaging studies in rheumatoid arthritis. Quinn M J Rheumatol; 2008 Mar; 35(3):372-4. PubMed ID: 18322971 [No Abstract] [Full Text] [Related]
7. Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al. Saxne T; Larsson L; Geborek P Arthritis Rheum; 2004 Sep; 50(9):3049-50; author reply 3050-1. PubMed ID: 15457477 [No Abstract] [Full Text] [Related]
8. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases. Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017 [No Abstract] [Full Text] [Related]
9. Assessing the value of rheumatoid arthritis treatment alternatives: the potential effect of tumor necrosis factor inhibitors. Mizutani W Manag Care Interface; 2003 Mar; 16(3):44-50, 55. PubMed ID: 12715413 [TBL] [Abstract][Full Text] [Related]